Want to see DOC full AI Analyst Report?
Revenue by Type
Breaks revenue into recurring rent, reimbursed tenant expenses, management fees, and one‑off items like property sales. Distinguishing recurring from non‑recurring revenue highlights how sustainable the company’s cash flow is and how exposed it is to volatile income sources.The huge March‑2026 jump in Resident Fees & Services aligns with the Janus Living IPO and prior on‑balance sheet senior‑housing buys, effectively bringing new recurring fee revenue onto Healthpeak’s P&L and underpinning the modest FFO lift and expected future ~$0.04/share accretion. Rental revenue earlier stepped up in mid‑2024 from outpatient/senior housing activity and has since stabilized, while interest income is immaterial. Positive revenue mix shifts support management’s capital‑deployment thesis, but refinancing and higher interest costs remain the primary near‑term risks to FFO conversion.
Date | Interest Income and Other | Rental and Related Revenue | Resident Fees & Services |
|---|---|---|---|
Jun 30, 2026 | $21.77M | $533.35M | $216.46M |
Mar 31, 2026 | $14.17M | $538.44M | $200.34M |
Dec 31, 2025 | $14.62M | $549.03M | $155.75M |
Sep 30, 2025 | $15.53M | $539.89M | $150.46M |
Jun 30, 2025 | $15.81M | $529.69M | $148.85M |
Mar 31, 2025 | $15.82M | $538.14M | $148.93M |
Dec 31, 2024 | $16.89M | $535.13M | $145.96M |
Sep 30, 2024 | $14.30M | $543.25M | $142.84M |
Jun 30, 2024 | $7.83M | $546.78M | $140.89M |
Mar 31, 2024 | $5.75M | $462.03M | $138.78M |